Soliqua 100/33 100 U/mL

Soliqua 100/33 is a combination of insulin glargine and lixisenatide, designed for subcutaneous administration. This solution is used to manage blood sugar levels in adults with type 2 diabetes.

Soliqua 100/33 is primarily used for the management of type 2 diabetes in adults. It combines insulin glargine, a long-acting insulin, with lixisenatide, a glucagon-like peptide-1 receptor agonist. This combination helps to control blood sugar levels by improving insulin response and reducing glucose production in the liver. People often ask, 'What is Soliqua 100/33 used for?' It is typically prescribed for those who require both types of medication to achieve optimal glycemic control.

Common effects of Soliqua 100/33 may include hypoglycemia, nausea, and injection site reactions. Some users may experience gastrointestinal discomfort or changes in appetite. It is important to monitor blood sugar levels regularly while using this medication.

Soliqua 100/33 should be stored properly to maintain its effectiveness. It is crucial to follow the prescribed dosage and administration instructions. Always consult a healthcare provider before starting or stopping this medication. Be aware of potential allergic reactions and inform your healthcare provider of any adverse effects.

Soliqua 100/33 may interact with other medications, including oral hypoglycemic agents, corticosteroids, and certain antidepressants. Alcohol consumption can also affect blood sugar levels and should be monitored. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.